Amid rising industry concerns about U.S. competitiveness with China, the Trump administration is rolling out four ARPA-H ...

Health care is undergoing an important and well-needed shift from a one-size-fits-all approach to more personalized, precise, patient-focused care. A similar approach needs to be implemented at scale ...

The new effort combines adaptive platform trial design, AI-enabled site activation, nationwide data infrastructure, and patient data contribution tools to reduce timelines, costs, and patient burden ...

Settling for “good enough” undermines clinical trial quality in drug development and risks trial failure and regulatory rejection. Here’s what pursuing greatness actually requires.

Innovations in clinical trial designs and tools have the potential to unlock a new era of research that is more convenient for patients, more reflective of real-world treatment conditions, and more ...

Using patient-centric trial design and biomarker insights to support confident development decisions Generating meaningful clinical insights as early as possible is a growing priority in ...

How can you design and execute early phase trials to get the results needed with limited resources and time? We need to balance what we can do and the resources we have with what needs to be done for ...

SAN FRANCISCO--(BUSINESS WIRE)--Unlearn®, a company at the forefront of AI in the clinical trial space, today announced the launch of TrialPioneer. This web-based application is free for teams in ...

Every patient in a clinical trial control arm adds cost and time. When that trial involves a serious or rare disease, it could also mean control-arm patients forgo a potentially beneficial treatment.

Systematic Review of the Diagnosis and Management of Malignant Extradural Spinal Cord Compression: The Cancer Care Ontario Practice Guidelines Initiative‘s Neuro-Oncology Disease Site Group Current ...

This activity was supported by contracts between the National Academy of Sciences and Advanced Regenerative Manufacturing Institute; Akron Biotech; Alliance for Regenerative Medicine; American Society ...

How can you design and execute early phase trials to get the results needed with limited resources and time? We need to balance what we can do and the resources we have with what needs to be done for ...